These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33654650)

  • 21. EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2.
    Okada M; Heeren TFC; Egan CA; Rocco V; Bonelli R; Fruttiger M
    Retina; 2018 Jan; 38 Suppl 1():S89-S96. PubMed ID: 28654457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.
    Dogan B; Erol MK; Akidan M; Suren E; Akar Y
    Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MACULAR TELANGIECTASIA TYPE 2 IN AN OTHERWISE HEALTHY TEENAGE BOY WITH CONSANGUINEOUS PARENTS.
    Ryu CL; Mikhail M; Khan A; Chen JC; Omar A
    Retin Cases Brief Rep; 2018 Summer; 12(3):200-203. PubMed ID: 27828905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical Coherence Tomography Angiography Findings in Type-2 Macular Telangiectasia.
    Nalcı H; Şermet F; Demirel S; Özmert E
    Turk J Ophthalmol; 2017 Oct; 47(5):279-284. PubMed ID: 29109897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen retinopathy and macular telangiectasia: A comparative case series.
    Venkatesh R; Sharief S; Jayadev C; Reddy NG; Mangla R; Agrawal R; Yadav NK; Chhablani J
    Eur J Ophthalmol; 2022 Nov; ():11206721221142637. PubMed ID: 36437624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.
    Heeren TFC; Tzaridis S; Bonelli R; Pfau M; Fruttiger M; Okada M; Egan C; Charbel Issa P; Holz FG
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1760-1767. PubMed ID: 31022297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis.
    Vance SK; Khan S; Klancnik JM; Freund KB
    Retina; 2011 Apr; 31(4):717-23. PubMed ID: 21386760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FUNDUS-WIDE SUBRETINAL AND PIGMENT EPITHELIAL ABNORMALITIES IN MACULAR TELANGIECTASIA TYPE 2.
    Powner MB; Woods SM; Zhu M; Gillies MC; Bernstein PS; Hageman GS; Comer GM; Egan C; Fruttiger M
    Retina; 2018 Jan; 38 Suppl 1():S105-S113. PubMed ID: 29045321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity?
    Venkatesh R; Nahata H; Reddy NG; Mishra P; Mangla R; Yadav NK; Chhablani J
    J Curr Ophthalmol; 2022; 34(4):428-435. PubMed ID: 37180535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
    Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
    Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease.
    Okada M; Egan CA; Heeren TFC; Tufail A; Fruttiger M; Maloca PM
    Retina; 2018 Jan; 38 Suppl 1():S97-S104. PubMed ID: 28834952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VASCULAR DISTORTION AND DRAGGING RELATED TO APPARENT TISSUE CONTRACTION IN MACULAR TELANGIECTASIS TYPE 2.
    Spaide RF; Marco RD; Yannuzzi LA
    Retina; 2018 Jan; 38 Suppl 1():S51-S60. PubMed ID: 28492432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2.
    Au A; Hou K; Baumal CR; Sarraf D
    JAMA Ophthalmol; 2018 Oct; 136(10):1182-1185. PubMed ID: 30054619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia.
    Reddy NG; Prabhu V; Sharma SV; Acharya I; Mangla R; Yadav NK; Chhablani J; Narayanan R; Venkatesh R
    Int J Retina Vitreous; 2023 Aug; 9(1):47. PubMed ID: 37559099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
    Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
    JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDENTIFICATION OF POSTERIOR SEGMENT PATHOLOGY WITH EN FACE RETINAL IMAGING USING MULTICOLOR CONFOCAL SCANNING LASER OPHTHALMOSCOPY.
    Feng HL; Sharma S; Stinnett S; Asrani S; Mruthyunjaya P
    Retina; 2019 May; 39(5):972-979. PubMed ID: 29474307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal imaging and functional correlations identify unusual cases of macular retinal pigment epithelium hypopigmentation occurring without functional loss.
    Boulanger-Scemama E; Akesbi J; Tick S; Mohand-Said S; Sahel JA; Audo I
    Doc Ophthalmol; 2017 Aug; 135(1):77-83. PubMed ID: 28593392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.